Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Medicaid Financing Changes Under the OBBBA: Provider Tax Waiver Final Rule and Caps on Medicaid Manager Care SDPs

By Sukrti Thonse & James A. Robertson on March 18, 2026
Email this postTweet this postLike this postShare this post on LinkedIn

Implementation of the One Big Beautiful Bill Act (OBBBA) continues to reshape Medicaid financing structures across the country. In early 2026, the Centers for Medicare & Medicaid Services (CMS) issued several regulatory actions that operationalize key OBBBA provisions that affect how states fund Medicaid programs and how hospitals receive supplemental payments.

Two developments that are particularly significant for providers are CMS’s Provider Tax Waiver Final Rule limiting certain state Medicaid financing arrangements and new CMS guidance imposing caps on Medicaid managed care State Directed Payments (SDPs).

Together, these changes may significantly alter Medicaid supplemental payment flows and introduce new fiscal uncertainty for hospitals, particularly those serving large Medicaid populations.

CMS Finalizes Provider Tax Waiver Rule

On January 29, 2026, CMS issued a final rule implementing OBBBA provisions restricting how states may use provider taxes to generate federal Medicaid matching funds. The rule becomes effective April 3, 2026.

Historically, some states relied on non-uniform or non-broad-based provider taxes, approved through federal waivers, to finance Medicaid supplemental payments and maintain program funding levels. The new rule narrows the circumstances under which such arrangements may qualify for federal approval and establishes phased compliance deadlines for existing waiver-based financing structures.

As a result, states relying heavily on waiver-supported provider taxes may need to restructure Medicaid funding models or identify alternative revenue sources.

For hospitals, these changes are significant because provider tax structures are often closely tied to:

  • Supplemental Medicaid payments
  • Medicaid Disproportionate Share Hospital (DSH) funding
  • State Medicaid program sustainability

The practical impact will vary across states depending on how heavily they relied on waiver-based financing arrangements.

CMS Caps Medicaid Managed Care State Directed Payments

On February 2, 2026, CMS released guidance implementing Section 71116 of the OBBBA, which governs Medicaid managed care State Directed Payments (SDPs).

The guidance limits certain SDP payments for hospitals, nursing facilities, and academic medical centers by capping reimbursement levels at a specified percentage of Medicare rates. States must revise payment arrangements exceeding these caps beginning with rating periods on or after July 4, 2025, although limited grandfathering provisions extend through 2028.

Over the past several years, SDPs have become a major source of supplemental Medicaid funding for hospitals, particularly in states with large managed care populations. The new caps could reduce available supplemental funding and force states and providers to revisit existing financing arrangements.

FY2026 Appropriations Bill Adjusts Medicaid DSH Cuts

The recently enacted FY2026 federal appropriations bill further modifies Medicaid hospital financing.

Most notably, the legislation delays and reduces previously scheduled Medicaid DSH cuts, scaling a planned three-year, $24 billion reduction down to an $8 billion cut beginning in fiscal year 2028.

While this postponement provides temporary relief, the law also changes how hospital-specific DSH limits are calculated. Under the revised methodology, Medicare, Medicare Advantage, and other primary payments must be deducted when calculating uncompensated care costs. This adjustment could materially affect hospitals serving large numbers of dual-eligible patients, potentially reducing allowable DSH payments.

What Hospitals Should Monitor

These developments reflect a broader trend emerging under OBBBA implementation: while Congress has softened certain funding reductions, it has simultaneously imposed tighter fiscal guardrails on Medicaid financing structures.

Hospitals should expect continued scrutiny of state financing mechanisms and should monitor how their state Medicaid agencies respond to the new federal requirements. Key areas to watch include:

  • State responses to CMS provider tax restrictions
  • Changes to Medicaid managed care SDP arrangements
  • Adjustments to Medicaid DSH calculations
  • Potential shifts in hospital supplemental payment programs

For providers with high Medicaid utilization, these policy changes could materially affect reimbursement levels and long-term financial planning.

Photo of Sukrti Thonse Sukrti Thonse

Associate, Corporate and Healthcare

Sukrti supports clients across a broad range of corporate and regulatory matters, advising at all stages of the business lifecycle with a strong concentration in healthcare and healthcare-adjacent industries. She regularly counsels physicians, medispas, multi-state provider groups, hospitals, and…

Associate, Corporate and Healthcare

Sukrti supports clients across a broad range of corporate and regulatory matters, advising at all stages of the business lifecycle with a strong concentration in healthcare and healthcare-adjacent industries. She regularly counsels physicians, medispas, multi-state provider groups, hospitals, and private equity sponsors on compliant corporate structuring, operational strategy, and growth initiatives. She provides guidance to healthcare start-ups, physician practices, and hospital systems on day-to-day operational, regulatory, and strategic matters, and assists clients in navigating complex and novel regulatory issues in highly regulated, multi-jurisdictional environments, including multi-state regulatory compliance and expansion.

In her corporate practice, Sukrti assists with the formation and capitalization of business structures and prepares key documents for fundraising, financing, and investor negotiations. She provides support on M&A transactions and in the structuring and implementation of Management Services Organization-Professional Corporation (MSO–PC) and Friendly PC models, ensuring compliance with Corporate Practice of Medicine (CPOM) doctrines, fee-splitting laws, and state ownership restrictions. Her work frequently involves advising on management services arrangements, equity structuring, rollover investments, and platform acquisitions involving physician-owned entities and private equity-backed healthcare companies.

Sukrti also has significant experience in physician and provider contracting, including drafting and negotiating employment agreements, independent contractor arrangements, professional services agreements, and compensation models (including wRVU-based structures), with careful attention to regulatory compliance and commercial reasonableness. Her practice includes coordinating regulatory due diligence and assisting with disclosure requirements, including for entities operating in FDA-regulated sectors.  She regularly structures and negotiates compensation arrangements with physicians in connection with employment and exclusive contracting arrangements, medical directorships, physician recruitment initiatives, office and equipment leases, and other key operational documents that support healthcare delivery and scalable platform growth.

She has developed particular strength in healthcare privacy and HIPAA compliance and works closely with firm partners to advise on federal and state regulatory frameworks. Sukrti regularly conducts multi-state regulatory analyses, including 50-state surveys addressing licensure, supervision, telehealth, reimbursement, and scope of practice considerations, enabling clients to expand across jurisdictions while mitigating regulatory risk.

Results may vary depending on your particular facts and legal circumstances.

Contact information:

sthonse@greenbaumlaw.com | 732.476.2480 | vCard

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

Read more about Sukrti ThonseEmailSukrti's Linkedin Profile
Show more Show less
Photo of James A. Robertson James A. Robertson

Partner and Practice Leader, Healthcare

Jim serves as trusted counsel to the entire healthcare sector. His practice spans the full spectrum of legal, regulatory, and corporate challenges facing healthcare entities.

With a deep technical command of reimbursement and payer strategy, Jim regularly represents…

Partner and Practice Leader, Healthcare

Jim serves as trusted counsel to the entire healthcare sector. His practice spans the full spectrum of legal, regulatory, and corporate challenges facing healthcare entities.

With a deep technical command of reimbursement and payer strategy, Jim regularly represents hospital systems and providers in high-stakes Medicare, Medicaid, and charity care subsidy matters. He possesses particular expertise in navigating disproportionate share hospital (DSH) and graduate medical education (GME) issues before state agencies and the federal Provider Reimbursement Review Board (PRRB). Jim further ensures the long-term sustainability of provider-payer relationships by negotiating complex Medicare Advantage and Managed Medicaid risk-sharing arrangements.

In the transactional arena, Jim provides comprehensive representation for mergers, acquisitions, joint ventures, and divestitures. He serves a diverse array of industry leaders, including for-profit and nonprofit hospital systems, academic medical centers, pharmaceutical companies, integrated delivery networks (IDNs), physician practices, and healthcare private equity funds. Jim is instrumental in the structural development of Clinically Integrated Networks (CINs), Accountable Care Organizations (ACOs), and Multiple Employer Welfare Arrangements (MEWAs), frequently securing necessary certifications from the New Jersey Department of Banking and Insurance (DOBI). His work encompasses the establishment and sale of individual and group practices, ambulatory surgery centers, nursing homes, and assisted living facilities, as well as the negotiation of executive contracts, recruitment initiatives, medical directorships, hospital department management, and office or equipment leases.

To mitigate operational risk, Jim guides clients through the development of robust corporate compliance programs and manages internal audits, government inquiries, and voluntary self-disclosures. His counsel ensures that provider arrangements satisfy the Stark Law, the federal Anti-Kickback Statute (AKS), and New Jersey’s Codey Law. He assists clients in seeking advisory opinions, obtaining Certificates of Need, and securing transaction approvals from the New Jersey Department of Health and the Attorney General under the Community Healthcare Asset Protection Act (CHAPA). His counsel ensures compliance with the Corporate Practice of Medicine (CPOM) doctrine and federal mandates including HIPAA, HITECH, the ACA, and Emergency Medical Treatment and Labor Act (EMTALA)—from drafting Business Associate Agreements (BAAs) to managing medical record retention and the physical or electronic storage of medical records.

Jim’s advocacy extends to medical staff matters, where he designs state-of-the-art bylaws and provides guidance on fair hearing requirements and strategic initiatives. Finally, he represents healthcare entities in business-critical litigation, including provider-payor disputes, restrictive covenant matters, and medical staff privileging hearings. By combining this granular knowledge of reimbursement and regulatory compliance with a veteran litigator’s perspective, Jim provides the strategic foresight necessary to navigate the administrative and operational hurdles of the modern healthcare landscape.

Results may vary depending on your particular facts and legal circumstances.

Contact information:

jrobertson@greenbaumlaw.com | 973.577.1784 | vCard | LinkedIn

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

Email
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Healthcare Perspectives
  • Organization:
    Greenbaum, Rowe, Smith & Davis LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo